Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-26

Clinical Trial Update: Taxoprexin Treatment for Advanced Skin Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial update reports completion of testing Taxoprexin in patients with advanced/metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Taxoprexin

Snippet

Sponsor: American Regent, Inc. | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED